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Abstract
Objectives. The sickle-cell trait phenotype is associated with
protection from malaria. Multiple molecular mechanisms have
been proposed to explain this protection, but the role of the host
immune system has been poorly investigated. We hypothesised
that cellular immunity to malaria may develop differently in sickle-
cell trait children (HbAS) and children with normal haemoglobin
(HbAA) repeatedly exposed to Plasmodium falciparum (Pf).
Methods. Paired samples collected prior to the Pf transmission
season and during the first malaria episode of the ensuing
transmission season from HbAS and HbAA children were analysed
by multiplex bead-based assay and comprehensive multi-
dimensional flow cytometry profiling. Results. Cellular immune
profiles were enriched in HbAS relative to HbAA children before
the start of the Pf transmission season, with a distinct NK subset.
These cells were identified as a novel subset of memory-activated
NK cells characterised by reduced expression of the ecto-enzyme
CD38 as well as co-expression of high levels of HLA-DR and
CD45RO. The frequency of this NK subset before the transmission
season was negatively correlated with parasite density quantified
during the first malaria episode of the ensuing transmission
season. Functional assessment revealed that these CD38dim
CD45RO+ HLA-DR+ NK cells represent a important source of IFN-c.
Conclusion. Our data suggest that this novel memory-activated NK
cell subset may contribute to an accelerated and enhanced IFN-c-
mediated immune response and to control of parasite density in
individuals with the sickle-cell trait. This distinct cellular immune
profile may contribute to predispose HbAS children to a relative
protection from malaria.
Keywords: haemoglobin AS, natural killer cells, parasite burden,
Plasmodium falciparum, protective immunity, sickle-cell trait
phenotype
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INTRODUCTION
The sickle-cell trait phenotype results from the
heterodimerisation of normal haemoglobin (Hb) A
with Hb presenting the b6 Glu ? Val single
amino acid substitution known as HbS. Whereas
the homodimerisation of mutated HbS is
responsible for the sickle-cell disease, which is
characterised by a chronic haemolytic anaemia, no
severe conditions are associated with the sickle-
cell trait phenotype (HbAS). On the contrary, it is
well established that individuals carrying the
heterozygous form HbAS are relatively protected
from malaria.1,2 Specifically, HbAS individuals
display a reduced mortality to Plasmodium
falciparum (Pf) infection,3 a reduced parasitaemia
during symptomatic malaria1,4-8 and a delayed
onset of malaria,8,9 as compared with HbAA
individuals. Moreover, the frequency of HbAS
individuals is particularly high in areas with
endemic Pf transmission.5,10
A number of molecular mechanisms have been
proposed to explain the relative protection from
malaria displayed by HbAS individuals, including
parasite growth inhibition in hypoxic condition,11-14
enhanced splenic clearance,13,15,16 altered
cytoadherence,17-19 translocation of HbS-specific
parasite growth-inhibiting microRNAs,20 induction of
haem oxygenase-121 and HbS polymerisation-
dependent parasite growth inhibition.18 A role for
the host immune system in the sickle-cell trait
phenotype-associated protection has been
tentatively proposed, but this has been poorly
explored.22-25 Few studies have considered the
importance of humoral immunity,26-30 but to the best
of our knowledge, there has been no investigation
of the role of host cellular immunity in the relative
protection of HbAS individuals frommalaria.
In malaria-endemic area, naturally acquired
immunity is known to develop slowly with age and
exposure.31-33 This immunity includes anti-disease
or clinical immunity, which protects against disease
symptoms, and anti-parasite immunity, which limits
blood-stage Plasmodium burden. IFN-c, a key
cytokine of the systemic immune response
produced by both innate and adaptive immune
cells, has been implicated in the protective
immunity to Pf infection.34-39 In humans, IFN-c
concentration is correlated with protection from
symptomatic malaria40 and resistance to Pf
reinfection.41,42 Ex vivo studies have demonstrated
that natural killer (NK) cells are the major source of
IFN-c during the very early immune response
following Pf infection.43,44 Although NK cells have
been traditionally defined as innate lymphocytes,
the existence of memory-like NK subsets, which
display an accelerated and enhanced recall
response following re-stimulation, has been
recently recognised.45-47 In the context of Pf
infection, a memory-like status of NK has been
suggested based on their adaptive T-cell-dependent
IFN-c response38 and their antibody-dependent
cellular toxicity towards parasitised red blood
cells.48 Most recently, in a Malian cohort of Pf-
exposed individuals, the frequency of an adaptive
NK subset has been correlated with protection
from malaria.49 Nonetheless, the IFN-c production
and frequency of IFN-c-producing cells, especially
of NK cell subsets, have yet to be explored in the
context of malaria immunity in HbAS individuals.
In this study, we hypothesised that cellular
immunity to malaria may develop differently in
HbAS and HbAA children repeatedly exposed to
Pf. Accordingly, we compared IFN-c-associated
immune profiles of HbAS and HbAA children from
a malaria-endemic area of Mali by evaluating (1)
the capacity of peripheral blood mononuclear
cells (PBMCs) to respond to stimulation, and (2)
the frequency of IFN-c-producing cell subsets in
total PBMCs, using paired samples collected prior
to the Pf transmission season as well as during the
first malaria episode of the ensuing transmission
season. We then focused our work on NK cells,
which were preferentially associated with sickle-
cell trait-mediated protection, and identified a
distinct subset of NK cells that was specifically
enriched in HbAS children compared to HbAA
children before the start of the Pf transmission
season. We defined the phenotypic profile of
these NK cells as CD38dim CD45RO+ HLA-DR+ and
characterised their functional profile.
RESULTS
HbAS children displayed an alteration of
their systemic inflammatory response
before the start of the Pf transmission
season
To investigate potential immune mechanisms
involved in the relative protection from malaria
associated with the sickle-cell trait phenotype, we
first compared the capacity of PBMCs isolated
from HbAS and HbAA children repeatedly
exposed to Pf to respond to stimulation. PBMCs
collected before the start of the Pf transmission
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season (baseline) and during the first malaria
episode of the ensuing transmission season
(malaria episode) were stimulated in vitro, and
the concentration of a broad range of cytokines
and chemokines was measured in supernatants.
Of all the cytokines and chemokines tested, only
IFN-c was significantly different between HbAS
and HbAA children before the start of the
Pf transmission season (Figure 1a). PBMCs isolated
from HbAS children showed a significantly higher
production of IFN-c than HbAA children (median
concentration 1494 pg mL!1 vs. 362 pg mL!1,
P < 0.0001; Figure 1b). No significant differences
were detected between HbAS and HbAA children
during the first malaria episode of the ensuing
Pf transmission season for IFN-c or any other
cytokine or chemokine (Figure 1c and d).
The frequency of NK cells is increased in
HbAS children before the start of the Pf
transmission season and correlates with the
time to the first malaria episode and with a
lower Pf density
Since our multiplex screening of cytokine and
chemokine production showed that HbAS and
HbAA children repeatedly exposed to Pf displayed
a significantly different IFN-c response before the
start of the transmission season, we next assessed
the frequency of PBMC subsets contributing to
the systemic IFN-c response. The frequency of
CD4+ T cells, CD8+ T cells, cd T cells, NKT and NK
cells in HbAS and HbAA children was determined
by flow cytometry (Supplementary figure 1). There
was no significant difference in the frequencies of
CD4+ T cells, CD8+ T cells, cd T cells or NKT cells
between HbAS and HbAA children before the
start of the Pf transmission season (median
frequency 30.1% vs. 26.8%, P = 0.479 for CD4+ T
cells; 23.9% vs. 27.1%, P = 0.362 for CD8+ T cells;
3.7% vs. 4.9%, P = 0.266 for cd+ T cells; 2.8% vs.
2.6% P = 0.292 for NKT cells; Figure 2a).
Surprisingly, NK cells were significantly more
frequent in HbAS children than in HbAA children
(median frequency 3.8% vs. 2.1%, respectively,
P = 0.014, Figure 2a).
We subsequently examined the frequency of NK
cells of all available paired samples collected
during the first malaria episode of the ensuing
transmission season. HbAS and HbAA children
displayed similar frequencies of NK cells (median
frequency 5.8% vs. 3.5%, P = 0.222; Figure 2b).
Figure 1. Cytokine and chemokine production in HbAS and HbAA children at baseline and during the first malaria episode of the ensuing Pf
transmission season. (a–d) Concentrations of cytokines and chemokines quantified in the supernatant of stimulated PBMCs isolated from (a, b)
HbAS children (n = 12) and HbAA children (n = 12) at baseline; or from (c, d) HbAS children (n = 5) and HbAA children (n = 8) during the first
malaria episode of the ensuing Pf transmission season. Cytokine and chemokine concentrations were assessed by MagPIX multiplex bead assays.
Groups were compared by Bonferroni’s multiple comparison test. ****P < 0.0001. (a, c) Heat maps represent the group means. (b, d) Horizontal
bars represent the median of the group. Technical replicate (n = 1).
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Because of the unavailability of some HbAS paired
samples at the time of the first malaria episode of
the ensuing Pf transmission season, statistical
analysis of the cell dynamic was compromised.
Analysis of available samples is presented in
Supplementary figure 2a.
Interestingly, the frequency of NK cells before
the start of the Pf transmission season was
significantly correlated with the time from the
start of the Pf transmission season to the first
malaria episode in HbAS children (q = 0.683,
P = 0.014; Figure 2c, left panel), but not in HbAA
children (q = 0.305, P = 0.251; Figure 2c, right
panel). Furthermore, the frequency of NK cells
before the start of the Pf transmission season was
significantly inversely correlated with the parasite
density quantified during the first malaria episode
of the ensuing transmission season in HbAS
children (q = !0.854, P = 0.030; Figure 2d, left
panel), but not in HbAA children (q = !0.323,
P = 0.435; Figure 2d, right panel). No significant
correlation was observed between the frequency
of NK cells before the start of the Pf transmission
season and the axillary temperature determined
during the first malaria episode of the ensuing
transmission season neither in HbAS children nor
in HbAA children (Supplementary figure 3a).
These data demonstrate that HbAS and HbAA
children repeatedly exposed to Pf differ in their
NK cell profile before the start of the Pf
Figure 2. Blood frequency of IFN-c-producing cells in HbAS and HbAA children at baseline and during the first malaria episode of the ensuing Pf
transmission season. (a) Blood frequency of CD4+ T cells, CD8+ T cells, cd T cells, NKT and NK cells in HbAS children (n = 12) and HbAA children
(n = 12) at baseline. Normality was assessed by the d’Agostino–Pearson normality test. Groups were compared by either an unpaired t-test or
the Mann–Whitney U-test depending on the normality. Median bars are shown. *P < 0.05. (b) Blood frequency of NK cells in HbAS children
(n = 5) and HbAA children (n = 8) during the first malaria episode of the ensuing Pf transmission season. Normality was assessed by the Shapiro–
Wilk normality test. Groups were compared by an unpaired t-test. Median bars are shown. (c, d) Correlation between the blood frequency of NK
cells at baseline and (c) the time from the start of the Pf transmission season to the first malaria episode and (d) the parasite density quantified
during the first malaria episode of the ensuing Pf transmission season in HbAS children (left panel, n = 6) and HbAA children (right panel,
n = 8). Pearson’s correlation coefficients are reported. Technical replicate (n = 1).
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transmission season and suggest that this distinct
cellular profile displayed by HbAS children may
predispose them to a relative protection from
malaria.
The frequency of the CD38high subset in NK
cells before the start of the Pf transmission
season correlates with Pf density during the
first malaria episode of the ensuing
transmission season
We have recently reported that the increased
expression of CD38, a multifunctional ecto-
enzyme, on CD4+ and CD8+ T cells is associated
with a reduced Pf and Plasmodium vivax density
in controlled human malaria infection studies.50,51
Therefore, we investigated whether significant
changes could be detected in CD38 expression on
NK cells of HbAS children compared to HbAA
children. Among CD38+ cells, we were able to
clearly distinguish two cell populations expressing
distinct level of CD38: CD38dim and CD38high
(Supplementary figure 1).
We first analysed the contribution of both
CD38dim and CD38high subset in the total pool of
NK cells. Before the start of the Pf transmission
season, HbAS and HbAA children did not display
significant difference regarding the blood
frequency of the CD38dim subset in NK cells
(median frequency 39.8% vs. 33.9%, P = 0.389;
Figure 3a, left panel), whereas the frequency of
the CD38high subset in NK cells of HbAS children
was significantly lower in HbAS children (median
frequency 37.5% vs. 49.4%, P = 0.027; Figure 3a,
right panel). Analysis of the cell dynamic between
baseline and the first malaria episode of the
ensuing Pf transmission season for available
samples is presented in Supplementary figure 2b
and c.
No significant correlation was observed
between the frequency of either the CD38dim or
the CD38high subset in NK cells before the start of
the Pf transmission season and the time from the
start of the Pf transmission season to the first
malaria episode neither in HbAS children nor in
HbAA children (Supplementary figure 3b and c).
The frequency of the CD38dim subset in NK cells
before the start of the Pf was not significantly
correlated with the parasite density quantified
during the first malaria episode neither in HbAS
children (q = !0.034, P = 0.949; Figure 3b, left
panel) nor in HbAA children (q = !0.144,
P = 0.734; Figure 3b, right panel). Also, the
frequency of the CD38high subset in NK cells and
the parasite density were significantly correlated
in HbAS children (q = 0.802 P = 0.017; Figure 3c,
left panel) but not in HbAA children (q = 0.116,
P = 0.784; Figure 3c, right panel), suggesting that
the CD38high fraction of NK cells is not involved in
the relative protection from malaria observed in
HbAS children repeatedly exposed to Pf. Similar to
our previous observation, none of the two CD38-
expressing subsets in NK cells showed a significant
correlation with the axillary temperature neither
in HbAS children nor in HbAA children
(Supplementary figure 3d and e).
CD38dim NK cells drive the increased
frequency of NK cells in HbAS children
before the start of the Pf transmission
season and are associated with the time to
the first malaria episode and with a lower
Pf density
Data presented above show that although the
frequency of NK cells as a whole in the circulating
blood of HbAS children was increased compared
to HbAA children (Figure 2a), the frequency of
the CD38high subset in NK cells was significantly
lower before the start of the Pf transmission
season in HbAS children than in HbAA children
(Figure 3a, right panel). Thus, the increased
frequency of NK cells in the total pool of PBMCs
observed in HbAS children was driven by CD38dim
NK cells (median frequency 1.6% vs. 0.7%,
P = 0.005; Figure 4a, left panel). The frequency of
CD38high NK cells was similar in HbAS and HbAA
children (median frequency 1.2% vs. 1.1%,
P = 0.768; Figure 4a, right panel). Analysis of cell
dynamic between baseline and the first malaria
episode of the ensuing Pf transmission season of
available paired samples is provided in
Supplementary figure 2d and e.
Remarkably, in HbAS children, we observed a
significant correlation between the frequency of
CD38dim NK cells before the start of the Pf
transmission season and the time from the start of
the Pf transmission season to the first malaria
episode (q = 0.602, P = 0.038; Figure 4b, left
panel), but not in HbAA children (q = 0.556,
P = 0.152; Figure 4b, right panel). The frequency
of CD38high NK cells was not significantly
correlated with the time from the start of the Pf
transmission season to the first malaria episode
neither in HbAS children (q = 0.139, P = 0.792;
Figure 4c, left panel) nor in HbAA children
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(q = 0.288, P = 0.489; Figure 4c, right panel).
Importantly, a significant negative correlation was
demonstrated between the frequency of CD38dim
NK cells of HbAS children before the start of the
Pf transmission season and the parasite density
quantified during the first malaria episode of the
ensuing transmission season (q = !0.897,
P = 0.015; Figure 4d, left panel). HbAA children
did not display such correlation (q = !0.421,
P = 0.299; Figure 4d, right panel). Neither HbAS
children (q = !0.517, P = 0.293; Figure 4e, left
panel) nor HbAA children (q = !0.334, P = 0.419;
Figure 4e, right panel) showed a significant
correlation between the baseline frequency of
CD38high NK cells and the parasite density. None
of the two NK subsets showed a significant
correlation with the axillary temperature neither
in HbAS children nor in HbAA children
(Supplementary figure 3f and g).
These data demonstrate that the alteration of
the NK cell frequency observed before the start of
the Pf transmission season in HbAS children
repeatedly exposed to Pf is driven by CD38dim NK
cells and suggest a key role for this cell subset in
the sickle-cell trait-mediated protection.
CD38dim NK cells display high IFN-c
production and reduced cytotoxic potential
The comprehensive multi-dimensional flow
cytometry analysis of HbAS and HbAA children
repeatedly exposed to Pf reported above shows
that before the start of the Pf transmission
season, the frequency of the CD38high subset in
NK cells was reduced (Figure 3a, right panel),
whereas the frequency of CD38dim NK cells in the
total pool of PBMCs was increased (Figure 4a, left
panel) in HbAS children compared to HbAA. Thus,
we next investigated the functional phenotype of
the CD38dim and CD38high populations of NK cells.
Given the unavailability of additional samples
from the HbAS children repeatedly exposed to Pf
included in this study, we further expanded our
investigation of these interesting cell populations
to include uninfected malaria-na€ıve donors.
PBMCs were isolated and then stimulated in vitro,
Figure 3. Frequency of CD38dim cells and CD38high cells in NK cells of HbAS and HbAA children at baseline and correlation with the parasite
density during the first malaria episode of the ensuing Pf transmission season. (a) Blood frequency of CD38dim cells (left panel) and CD38high
(right panel) cells in NK cells of HbAS children (n = 12) and HbAA children (n = 12) at baseline. Normality was assessed by the d’Agostino–
Pearson normality test. Groups were compared by an unpaired t-test. Median bars are shown. *P < 0.05. (b-c) Correlation between the blood
frequency of either (b) CD38dim cells or (c) CD38high cells in NK cells at baseline and the parasite density quantified during the first malaria
episode of the ensuing Pf transmission season in HbAS children (left panel, n = 6) and HbAA children (right panel, n = 8). Pearson’s correlation
coefficients are reported. Technical replicate (n = 1).
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and NK cells were segregated for analysis
according to their distinct expression of CD38.
Measurement of the intracellular expression of
IFN-c and TNF-a (Supplementary figure 4) revealed
that the CD38dim and CD38high NK cell subsets
differed in their cytokine production profiles.
Specifically, the frequency of IFN-c-producing cells
was significantly higher in the CD38dim NK subset
than the CD38high NK subset (median frequency
29.8% vs. 9.4%, P = 0.031; Figure 5a, left panel),
whereas the frequency of TNF-a-producing cells
was significantly reduced in the CD38dim NK
subset compared to the CD38high NK subset
(median frequency 37.2% vs. 43.4%, P = 0.003;
Figure 5a, middle panel). Examination of poly-
functionality revealed that the CD38dim NK cells
were significantly enriched in cells co-expressing
IFN-c and TNF-a compared to their CD38high
counterparts (median frequency 12.7% vs. 3.2%,
P = 0.034; Figure 5a, right panel). Moreover, the
production of IFN-c as indicated by the mean
fluorescence intensity (MFI) was significantly
higher in the CD38dim NK subset than the
CD38high NK subset (median MFI 233.0 vs. 172.5,
P = 0.039; Figure 5b, left panel), whereas the
production of TNF-a was significantly lower in the
Figure 4. CD38dim and CD38high NK cells of HbAS and HbAA children at baseline, correlation with the time to malaria episode and with the
parasite density. (a) Blood frequency of CD38dim (left panel) and CD38high (right panel) NK cells of HbAS children (n = 12) and HbAA children
(n = 12) children at baseline. Normality was assessed by the d’Agostino–Pearson normality test. Groups were compared by an unpaired t-test.
Median bars are shown. **P < 0.01. (b, c) Correlation between the blood frequency either (b) CD38dim NK cells or (c) CD38high NK cells at
baseline and the time from the start of the Pf transmission season to the first malaria episode. (d, e) Correlation between the blood frequency
either (d) CD38dim NK cells or (e) CD38high NK cells at baseline and the parasite density quantified during the first malaria episode of the ensuing
Pf transmission season. (b–e) HbAS children (n = 6) are shown in the left panel, and HbAA (n = 8) children are shown in the right panel.
Pearson’s correlation coefficients are reported. Technical replicate (n = 1).
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CD38dim NK subset than the CD38high NK subset
(median MFI 255.5 vs. 296.0, P = 0.009; Figure 5b,
right panel).
As secretion of cytotoxic granules is also a
functional hallmark of NK cells, we next assessed
the production of perforin and Granzyme-B by
CD38dim and CD38high NK cells (Figure 5c and d).
Consistent with the observed differences between
CD38dim and CD38high NK cells with regard to
cytokine production, these two subsets also
differed in their cytotoxic potential. Specifically,
the frequencies of perforin+ and Granzyme-B+
cells were significantly lower in the CD38dim NK
subset than the CD38high NK subset (median
frequency 48.0% vs. 80.7%, P = 0.007 for
perforin+ cells; and 53.9% vs. 83.9%, P = 0.015 for
Granzyme-B+ cells, respectively; Figure 5c, left and
middle panel). The CD38dim NK subset contained a
significantly lower proportion of cells co-
expressing perforin and Granzyme-B (46.9% vs.
79.5%, P = 0.005; Figure 5c, right panel).
Additionally, the production of perforin in the
CD38dim NK subset was approximatively 2.5-fold
lower than in the CD38high NK subset and
Granzyme-B production was lower by
approximatively 4.5-fold (median frequency 841.5
vs. 2106, P = 0.002 for perforin; and 1201 vs. 4975,
P = 0.005 for Granzyme-B, respectively; Figure 5d).
Finally, we determined the contribution of both
CD38dim NK subset and CD38high NK subset to the
production of IFN-c, TNF-a, perforin and
Granzyme-B in the total pool of NK cells
(Figure 5e). The CD38dim NK subset was the major
source of IFN-c, representing approximatively 65%
Figure 5. Functional phenotype of CD38dim NK cells and CD38high NK cells. (a) Frequency of IFN-c+ (left panel), TNF-a+ (middle panel) and
IFN-c+ TNF-a+ (right panel) cells. (b) IFN-c (left panel) and TNF-a (right panel) MFI. (c) Frequency of perforin+ (left panel), Granzyme-B+
(middle panel) and Granzyme-B+ perforin+ (right panel) cells. (d) perforin (left panel) and Granzyme-B (right panel) MFI. (a–d) Frequency
and MFI were determined in CD38dim NK cells (n = 6) and CD38high NK cells (n = 6). (e) Contribution of CD38dim NK cells, CD38high NK cells and
CD38neg NK cells in the total pool of IFN-c+, TNF-a+, perforin+ and Granzyme-B+ NK cells (n = 6). Normality was assessed by the Shapiro–Wilk
normality test. Groups were compared by either an paired t-test or the Wilcoxon’s matched-pairs signed rank test depending on the normality.
*P < 0.05; **P < 0.01. Technical replicate (n = 1). MFI, mean fluorescence intensity.
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of the IFN-c-producing NK cell pool. On the
contrary, TNF-a, perforin and Granzyme-B
production in the total pool of NK cells was
largely supported by the CD38high NK subset,
representing approximatively 68%, 89% and 88%
of the productive cells, respectively.
The CD38dim NK subset is enriched in
memory-activated cells
We next looked in more detail into the
phenotype of in vitro stimulated malaria-na€ıve
CD38dim and CD38high NK cells. A strong and rapid
production of IFN-c and Granzyme-B following
Mycobacterium spp. stimulation has been
previously linked to the uncommon expression of
CD45RO or HLA-DR on NK cells.45,52 Thus, we
hypothesised that the high capacity of CD38dim
NK cells to generate a strong IFN-c response could
be associated with expression of memory- and/or
activation-associated molecules. Flow cytometry
analysis of CD45RO+ and HLA-DR+ cells
(Supplementary figure 5) revealed significant
higher frequency of both cell populations in the
CD38dim NK subset than the CD38high NK subset
(median frequency 14.0% vs. 0.65%, P = 0.0005
for CD45RO+ cells and 19.0% vs. 4.6%, P = 0.0009
for HLA-DR+ cells; Figure 6a). Importantly, these
observations were validated in vivo in PBMCs
collected before the start of the Pf transmission
season from our cohort of Malian individuals
repeatedly exposed to Pf (median frequency 4.7%
vs. 0.8%, P < 0.0001 for CD45RO+ cells and 11.7%
vs. 4.3%, P < 0.0001 for HLA-DR+ cells; Figure 6b).
CD38dim NK cells were also significantly enriched
in cells expressing NKG2C, a NK-specific activating
receptor described on adaptive NK cells in the
context of CMV infection,53-55 as demonstrated by
in vitro stimulation of malaria-na€ıve PBMCs
(median frequency 18.9% vs. 7.5%, P < 0.0001;
Figure 6c and Supplementary figure 6). In both
uninfected malaria-na€ıve donors and Pf-exposed
Malian individuals, CD38dim NK cells retained a
CD56dim phenotype (median frequency 88.2%
in malaria-na€ıve individuals and 82.8% in Pf-
exposed; Figure 6d).
To further determine to what extent cells
expressing memory- or activation-associated
molecules were responsible for the cytokine and
cytotoxic molecule production detected in the
CD38dim NK cell subset, we determined correlation
coefficients between the frequency of CD45RO-
and HLA-DR-expressing CD38dim NK cells and the
frequency of producing cells, or the production
capacity. Importantly, the frequency of the
CD45RO+ cell subset in CD38dim NK cells was
positively correlated with the frequency of IFN-c-
producing cells in CD38dim NK cells (q = 0.943,
P = 0.017; Figure 6e, left panel) and the capacity
of CD38dim NK cells to produce IFN-c (q = 0.847,
P = 0.033; Figure 6e, right panel), suggesting that
the CD45RO+ subset is the main source of IFN-c in
CD38dim NK cells. A similar correlation was
observed between HLA-DR+ cells in CD38dim NK
cells and IFN-c-producing cells in CD38dim NK cells
(q = 0.943, P = 0.017; Figure 6f, left panel) as well
as with their IFN-c production (q = 0.875,
P = 0.022; Figure 6f, right panel), suggesting that
IFN-c-producing CD45RO+ HLA-DR+ CD38dim NK
cells might constitute a single distinct subset of
NK cells. These observations are consistent with
the CD45RO+ and HLA-DR+ NK subsets being
responsible for a robust IFN-c response, as
noted previously for Mycobacterium spp.45,52
Remarkably, CD45RO+ cells in CD38dim NK cells
and HLA-DR+ cells in CD38dim NK cells were both
negatively correlated with perforin-producing
CD38dim NK cells (q = !0.714, P = 0.136 for
CD45RO+ cells and q = !0.886, P = 0.033 for HLA-
DR+ cells; Figure 6g and h, left panel) and
perforin production (q = !0.771, P = 0.103 for
CD45RO+ cells and q = !0.755, P = 0.083 for HLA-
DR+ cells; Figure 6g and h, right panel).
CD45RO+ HLA-DR+ CD38dim NK cells
constitute a single distinct subset of NK
cells displaying strong IFN-c response
following stimulation
We next investigated whether CD45RO+ cells and
HLA-DR+ cells constituted two distinct subsets of
CD38dim NK cells or a single subset co-expressing
both markers. Flow cytometry analysis revealed
that HLA-DR+ CD38dim NK cells were significantly
enriched in CD45RO+ compared to HLA-DR+
CD38high (median frequency 55.2% vs. 16.1%,
P = 0.003; Figure 7a). Similarly, there was a
significantly higher frequency of HLA-DR+ cells in
CD45RO+ CD38dim NK cells than CD45RO+ CD38high
NK cells (median frequency 85.5% vs. 73.4%,
P = 0.042; Figure 7b). Therefore, the frequency of
CD45RO+ HLA-DR+ double-positive cells was
evaluated in CD38dim and CD38high NK cells. Our
data showed that CD45RO+ HLA-DR+ cells were
significantly more frequent in CD38dim NK cells
than CD38high NK cells (median frequency 12.5%
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vs. 0.6%, P = 0.0005; Figure 7c, left panel).
Importantly, similar results were also observed
in vivo in PBMCs collected before the start of the
Pf transmission season from our cohort of Malian
individuals repeatedly exposed to Pf (median
frequency 1.9% vs. 0.2%, P < 0.0001; Figure 7c,
right panel). In accordance with our previous
observations, the frequency of CD45RO+ HLA-DR+
cells in CD38dim NK cells was significantly
correlated with the frequency of IFN-c-producing
cells in CD38dim NK cells (q = 0.817, P = 0.047;
Figure 7d, left panel), whereas it was significantly
inversely correlated with perforin-producing
CD38dim NK cells (q = !0.886, P = 0.033;
Figure 7d, right panel).
Finally, we investigated the functional relevance
of these correlations. Functional exploration of
in vitro stimulated malaria-na€ıve CD45RO+ HLA-
DR+ NK cells segregated for the analysis based on
CD38 expression (Supplementary figures 4 and 5)
revealed a significantly higher frequency of IFN-c+
cells and IFN-c+ TNF-a+ cells in CD45RO+ HLA-DR+
CD38dim NK cells than their CD38high counterparts
(median frequency 80.2% vs. 29.9%, P = 0.0005
for IFN-c+ cells; 58.6% vs. 43.8%, P = 0.016 for
IFN-c+ TNF-a+ cells; Figure 7e). In contrast,
CD45RO+ HLA-DR+ CD38dim NK cells displayed a
reduced frequency of TNF-a+ cells (median
frequency 86.1% vs. 94.7%, P = 0.062; Figure 7e).
Consistent with the result reported for the
CD38dim NK cell subset as a whole (Figure 5),
CD45RO+ HLA-DR+ CD38dim NK cells showed a
significantly reduced cytotoxic potential as
assessed by their frequencies of perforin+ cells
Figure 6. In vitro and in vivo expression of CD45RO and HLA-DR on CD38dim NK cells and CD38high NK cells and correlation with production of
IFN-c and perforin. (a, b) In vitro (a) and in vivo (b) determination of CD45RO+ cell (left panel) and HLA-DR+ cell (right panel) frequency in
CD38dim NK cells (n = 12 in vitro and n = 24 in vivo) and CD38high NK cells (n = 12 in vitro and n = 24 in vivo). (c) Frequency of NKG2C+ cells in
CD38dim NK cells and CD38high NK cells (n = 12). (d) Frequency of CD56dim cells in CD38dim NK cells in both malaria-na€ıve (n = 12) and Pf-
exposed individuals (n = 24). (a–d) Normality was assessed by the d’Agostino–Pearson normality test. Groups were compared by either a paired
t-test or the Wilcoxon’s matched-pairs signed rank test depending on the normality. ***P < 0.001; ****P < 0.0001. (e, f) Correlation between
the frequency of either (e) CD45RO+ cells in CD38dim NK cells or (f) HLA-DR+ cells in CD38dim NK cells and the frequency of IFN-c+ cells in
CD38dim NK cells (left panel), and IFN-c production (right panel), (n = 6). Spearman’s correlation coefficients are reported. (g, h) Correlation
between the frequency of either (g) CD45RO+ cells in CD38dim NK cells or (h) HLA-DR+ cells in CD38dim NK cells and the frequency of perforin+
cells in CD38dim NK cells (left panel), and perforin production (right panel), (n = 6). Spearman’s correlation coefficients are reported. Technical
replicate (n = 1).
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(median frequency 1.8% vs. 22.2%, P = 0.024;
Figure 7e) and Granzyme-B+ cells (median
frequency 1.13% vs. 17.1%, P = 0.027; Figure 7e).
Additionally, CD45RO+ HLA-DR+ CD38dim NK cells
contained a lower proportion of cells co-
expressing perforin and Granzyme-B (median
frequency 0.3% vs. 12.6%, P = 0.051; Figure 7e).
Taken together, this study provides the first
evidence implicating host cellular immunity in
HbAS-associated immune response to Pf infection.
We also describe for the first time the existence of
a CD38dim NK subset displaying a memory-
activated phenotype and demonstrate that
cellular immune profiles enriched with this
distinct NK subset before the start of the Pf
transmission season are associated with better
parasite control during a subsequent malaria
episode. Our data suggest that these memory-
activated CD38dim NK cells represent an important
source of IFN-c production, facilitating parasite
control in HbAS individuals.
DISCUSSION
Herein, we report for the first time evidence
supporting the existence of a distinct cellular
immunity between HbAS and HbAA children
repeatedly exposed to Pf. Our work points out the
existence of a novel NK cell subset that expresses
a reduced level of CD38 and co-expresses high
levels of HLA-DR and CD45RO, representing a
memory-activated phenotype. Functional
assessment revealed that the CD38dim CD45RO+
HLA-DR+ NK cells represent an important source
of IFN-c. We further showed that these CD38dim
NK cells were specifically enriched in HbAS
children compared to HbAA children before the
start of the Pf transmission season, and were
Figure 7. Identification of the CD45RO+ HLA-DR+ CD38dim NK cell subset and functional characterisation. (a) Frequency of CD45RO+ cells in
HLA-DR+ CD38dim NK cells (n = 12) and HLA-DR+ CD38high NK cells (n = 12). (b) Frequency of HLA-DR+ cells in CD45RO+ CD38dim NK cells
(n = 12) and CD45RO+ CD38high NK cells (n = 12). (c) Frequency of CD45RO+ HLA-DR+ cells in CD38dim NK cells and CD38high NK cells
determined in vitro (left panel, n = 12) and in vivo (right panel, n = 24). (a–c) Normality was assessed by the d’Agostino–Pearson normality
test. Groups were compared by Wilcoxon’s matched-pairs signed rank test. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. (d)
Correlation between the frequency of CD45RO+ HLA-DR+ cells in CD38dim NK cells and the frequency of IFN-c+ cells in CD38dim NK cells (left
panel, n = 6) and with the frequency of perforin+ cells in CD38dim NK cells (right panel, n = 6). Spearman’s correlation coefficients are
reported. (e) Frequency of IFN-c+ cells, TNF-a+ cells, IFN-c+ TNF-a+ cells, perforin+ cells, Granzyme-B+ cells and Granzyme-B+ perforin+ cells in
CD45RO+ HLA-DR+ CD38dim NK cells and CD45RO+ HLA-DR+ CD38high NK cells (n = 6). Normality was assessed by the Shapiro–Wilk normality
test. Groups were compared by either a paired t-test or Wilcoxon’s matched-pairs signed rank test depending on the normality. *P < 0.05;
***P < 0.001. Technical replicate (n = 1).
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associated with a longer period between the start
of the transmission season and the first malaria
episode as well as with a better parasite control
during this subsequent malaria episode.
Therefore, our study suggests that memory-
activated NK cells present before the start of the
Pf transmission season may contribute to control
parasites and delay the onset of the next malaria
episode in HbAS children by producing an
accelerated and enhanced IFN-c response.
There is considerable evidence highlighting the
importance of parasite-induced IFN-c responses in
the control of Pf malaria, including correlation
with protection from symptomatic malaria40,56
and resistance to Pf reinfection.41,42 Moreover, the
intensity and rapidity of the IFN-c response has
been associated with both anti-parasite
immunity57 and clinical immunity.58 Our work
demonstrates for the first time that circulating
PBMCs isolated before the start of the
transmission season from Pf-exposed HbAS
individuals display a higher IFN-c response to
stimulation than HbAA individuals. We further
dissected the cellular sources responsible for this
early IFN-c response. Among all the IFN-c-
producing cells explored in our study, we show
that NK cells are the only cell subset with a
significantly increased frequency in HbAS
individuals compared to HbAA before the start of
the Pf transmission season. More importantly, the
frequency of NK cells present before the start of
the transmission season in the peripheral blood of
HbAS children was significantly correlated with
the time from the start of the Pf transmission
season to malaria episode as well as with the
capacity to control parasite density.
Although NK cells are often considered as a
bulk population of cells expressing CD56, they
constitute a highly heterogeneous cellular
compartment of the immune system.59-61 Similar
to T cells, multiple subsets of NK cells can be
distinguished based on the expression of a variety
of surface receptors and production of immune
mediators, with CD56bright NK cells being
generally considered as relatively immature cells
with high cytokine production capacity, whereas
CD56dim NK cells are more mature cells associated
with a high cytotoxic activity.59,62 Heterogeneity
of the NK cell response has been demonstrated in
Pf infection.63 In the present study, by assessing
the expression level of the ecto-enzyme CD38, we
identified a CD38dim and a CD38high NK subset.
Further analyses demonstrated that CD38dim and
CD38high NK cells display a heterogeneous
capacity to produce cytokines and cytotoxic
mediators. Although in our study both CD38dim
and CD38high NK cell subsets were able to produce
IFN-c, TNF-a and cytotoxic granules following
stimulation, the CD38dim NK cell subset
preferentially expressed high levels of IFN-c, even
though more than 80% of the cells were CD56dim.
Importantly, the CD38dim NK cell subset was the
major source of IFN-c in the total pool of NK cells.
Such dichotomy between cytokine production and
cytotoxic activity has been previously observed on
terminally differentiated CD57+ NK cells in the
context of antiviral response.64 Moreover, even if
our analysis did not show any significant
difference when comparing the frequency of
CD56dim cells in CD38high NK cells and CD38dim NK
cells of malaria-na€ıve individuals (P = 0.266;
Supplementary figure 7a), we observed that the
frequency of CD56dim cells was significantly higher
in the CD38high NK subset than CD38dim NK subset
of Pf-exposed children (P < 0.0001; Supplementary
figure 7b). Therefore, the relatively lower
proportion of CD56dim cells in the CD38dim NK cell
subset could partially explain their reduced
capacity to produce cytotoxic granules. Although,
we can not exclude that the lower expression of
CD38 may also partly explain the reduced release
of Perforin and Granzyme-B by CD38dim NK cells
as signalling through this ecto-enzyme has been
previously associated with induction of cytotoxic
activity on NK cells.65,66
Importantly, we demonstrated that HbAS
individuals display a significantly higher frequency
of CD38dim NK cells than HbAA individuals before
the start of the Pf transmission season. Moreover,
we show that the enrichment in CD38dim NK cells
at baseline is associated with both a delay onset
of the next malaria episode and a relative control
of parasite density during this episode in HbAS
individuals. Previously, a blood-stage controlled
human malaria infection study by our group
associated CD4+ T cells expressing CD38 with
reduced Pf density in malaria-na€ıve volunteers
exposed to Pf for the first time50,51; however, NK
cells were not investigated in that study. Of note,
in our current study, analysis of CD4+ T cells
expressing either CD38dim or CD38high did not
reveal any significant difference between HbAS
and HbAA children repeatedly exposed to Pf
(Supplementary figure 8).
The expression of CD45RO at the surface of T
cells is conventionally used to discriminate their
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memory and na€ıve status, whereas the expression
of HLA-DR is used to assess their activation status.
However, CD45RO and HLA-DR expression on NK
cells has been reported.45,52,67,68 Herein, we were
able to detect both CD45RO and HLA-DR on the
surface of NK cells in both uninfected malaria-
na€ıve adults and children repeatedly exposed to
Pf. We further showed that the CD38dim NK
subset was particularly enriched in both CD45RO+
cells and HLA-DR+ cells as compared to its
CD38high counterpart, suggesting that CD38dim NK
cells have a memory-activated phenotype. These
exciting findings were supported by the high
expression of NKG2C, the CD56dim phenotype and
the high cytokine production versus reduced
cytotoxic potential observed on CD38dim NK cells.
Similar to memory mechanisms observed in the T-
cell compartment, establishment and maintenance
of the memory-activated CD38dim NK cell
compartment might constitute in HbAS children
an adaptive-like mechanism for optimising the
initiation of a very early and strong immune
response following Pf re-exposure. In both mice
and human, maintenance of memory NK cells has
been reported several months post-infection.69,70
To our knowledge, mechanisms supporting the
maintenance of memory NK cells in the circulating
blood remain unclear. A distinct chemokine
receptor profile might allow memory-activated
CD38dim NK cells to patrol through the circulating
blood to the peripheral organs.71 Also, specific
cytokine environment, for example enriched with
IL-15, might support the maintenance of such
memory NK cells in the circulating blood.72
Alternatively, we cannot exclude that a subclinical
infection (below the detection limit of the Pf-
PCR73) might support the maintenance of a
memory-activated CD38dim NK cell compartment
in the blood.
Finally, we identified a CD38dim NK subset co-
expressing both CD45RO and HLA-DR. Functionally,
the expression of either CD45RO or HLA-DR on NK
cells has been previously associated with strong
IFN-c and cytotoxic responses following
stimulation.45,52,67 Consistent with those reports,
our experiments showed that CD45RO+ HLA-DR+
CD38dim NK cells exerted high IFN-c responses
following stimulation. However, in contrast to
previous studies on CD45RO+ NK cells and HLA-DR+
NK cells, we observed a reduced cytotoxic response
on CD45RO+ HLA-DR+ CD38dim NK cells, possibly
because of their reduced expression of CD3865,66
and/or their more mature status.64
The existence of memory NK cells was first
established in rodent models.74-76 The importance
of such NK cells has since been highlighted in
non-human primates infected with the simian–
human immunodeficiency virus77 and in human
infected by Mycobacterium tuberculosis45 or
CMV53-55; as well as in vaccinated
individuals.46,52,78 Recently, a high frequency of
NKdim NKG2C+ CD57+ memory-like cells at the
time of primary HIV infection was associated with
an enhanced early control of the viral load under
combined antiretroviral therapy.79 In the context
of Pf infection, the expression of the DNAX
accessory molecule 1, a co-stimulatory molecule
found essential for the differentiation of memory
NK cells,80 was associated with the NK ability to
eliminate parasitised red blood cells.81 More
recently, the frequency of an antibody-dependent
memory-like NK cell subset has been correlated
with low parasitaemia and resistance to malaria.49
Herein, by identifying the existence of a novel
memory-activated NK cell subset characterised by
the CD38dim CD45RO+ HLA-DR+ phenotype, we
show for the first time the involvement of cellular
immunity in the HbAS-associated immune
response to Pf infection. Our results show that the
enrichment in CD38dim NK cells before the start of
the Pf transmission season plays a key role in the
better parasite control observed in HbAS children
during the first malaria episode of the ensuing
transmission season. Our study has important
implications for the understanding of immunity to
malaria and the development of effective
therapeutic interventions. These data suggest that
the induction of an adaptive/memory NK response
should be considered in the design of new vaccine
candidates against Plasmodium infection.
METHODS
Subjects
Subjects included in the study presented herein were a
subset from individuals aged 3 months to 25 years, enrolled
in a previously described cohort study.82 Briefly, a
prospective cohort study was conducted in Kalifabougou,
Mali, where intense seasonal Pf transmission occurs during
a predictable 6-month period from July through December
and where repeated infections are common.82 At baseline
(before the start of the Pf transmission season), all subjects
displayed a haemoglobin level > 7 g dL!1, an axillary
temperature ≤ 37.5°C and were free of acute systemic
illness and chronic disease. Malaria episodes were detected
by passive (self-reporting to local health centre) and active
(medical examination and PCR, every 2 weeks from
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enrolment through December) surveillance. Malaria
episodes were defined as parasitaemia ≥ 2500
parasites lL!1, an axillary temperature > 37.5°C and/or signs
and symptoms consistent with malaria.82
Here, we focus on individuals aged 7–13 years, which is
the age range during which the acquisition of clinical
immunity to uncomplicated malaria begins in areas of
intense malaria transmission. From this subset, we randomly
selected 12 HbAA and 12 HbAS children free of Pf infection
(as by PCR), with blood samples and clinical data available
before the start of the Pf transmission season (Table 1). At
the first malaria episode of the ensuing transmission
season, paired clinical data were available for 8 HbAA and
6 HbAS individuals (Table 1) and paired blood samples were
available for 8 HbAA and 5 HbAS individuals. The four
groups were similar in terms of gender ratio (P = 0.551),
body weight (P = 0.460), age (P = 0.741) and haemoglobin
concentration (P = 0.225) (Table 1). During the first malaria
episode, the axillary temperature was significantly increased
in HbAA children (P = 0.003; Table 1) and HbAS children
(P = 0.025; Table 1) compared to baseline.
Samples
Venous blood (≤ 8 mL) was collected at baseline and at the
time of the first malaria episode into sodium heparin tubes
(BD Vacutainer CPT, Franklin Lakes, NJ) and transported to
the local laboratory for processing within 3 h of collection.
PBMCs were isolated by standard density gradient
centrifugation and stored at !80°C overnight before long-
term storage in liquid nitrogen.
Haemoglobin type
Haemoglobin typing for HbA, HbS and HbC was
determined by high-performance liquid chromatography
using a D-10 haemoglobin analyser (Bio-Rad, Hercules, CA).
Parasite density
Parasite density was quantified from genomic DNA of Pf
asexual parasites extracted from dried blood spots as
previously described.73 Briefly, the Pf 18S rRNA gene was
amplified by 15-cycle standard PCR amplification followed
by a qPCR. The limit of detection of the nested qPCR was
~0.5 parasites lL!1.
Cytokine and chemokine quantification
Concentrations of IFN-c, IL-1b, IL-6, IL-12p70, IL-17A, IP-10,
MCP-1, MIP-1a, MIP-1b and TNF-a were quantified in the
supernatant of PBMCs stimulated with 20 ng mL!1 of PMA
and 1000 ng mL!1 of Ionomycin (Sigma-Aldrich, St. Louis,
MO) for 6 h at 37°C by using the Human ProcartaPlex
Panel (Invitrogen, Carlsbad, CA) following the
manufacturer’s instructions. Detection was performed using
a MagPIX analyser driven by xPONENT software (Luminex
Corporation, Austin, TX).
Immunophenotyping of peripheral blood
lymphocytes
Peripheral blood mononuclear cells isolated from peripheral
blood samples from HbAS and HbAA children were
stimulated with 20 ng mL!1 of PMA and 1000 ng mL!1 of
Ionomycin (Sigma-Aldrich) for 6 h at 37°C. Cells were then
stained for 20 min with phenotype-associated markers with
anti-human CD3-APC-H7 (SK7), CD4-BUV495 (SK3), CD56-PE
(B159) (all from BD Biosciences, Franklin Lakes, NJ), CD8-Pe-
Cy7 (SK1; BioLegend, San Diego, CA) and TCRcd-FITC (5a6E9;
Invitrogen); and for activation/memory-associated markers
with anti-human CD45RO-BV510 (UCHL1; BioLegend) and
HLA-DR-PerCP-Cy5.5 (G46-6; BD Biosciences); and with anti-
human CD38-BV650 (HB-7; BioLegend), monoclonal
antibodies (mAbs). Samples were then analysed using a BD
Table 1. Clinical characteristics
Baseline Malaria episode
P value
HbAA HbAS HbAA HbAS
(n = 12) (n = 12) (n = 8) (n = 6)
Gender ratio (F/M) 1.00 0.50 1.67 0.50 NSb
Body weight (kg)a 20.0 [17–40] 23.0 [19–34] 21.5 [17–29] 23.0 [19–37] NSc
Axillary temperature (°C)a 36.4 [35.9–36.8] 36.5 [36.0–37.1] 38.4 [36.0–39.8] 37.3 [37.0–39.0] HbAA P < 0.01d
HbAS P < 0.05d
Age (years)a 8 [7–12] 9 [7–13] 8.5 [7–11] 8.5 [7–13] NSc
Haemoglobin concentration
(g dL!1)a
12.3 [10.1–13.9] 11.5 [10.6–13.9] 11.6 [9.6–14.6] 11.9 [10.0–13.4] NSe
Parasite density (parasites lL!1)a 58 425 [2725–235 725] 17 850 [4050–58 700] NSf
P < 0.05 indicates a significant difference in axillary temperature measured at baseline and during malaria episode in HbAA individuals.
F, female; Hb, haemoglobin; M, male; NS, not significant.
a










Unpaired t-test with Welch’s correction.
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LSRFortessa X20 driven by FACSDiva software (BD
Biosciences). FlowJo software version 10.4 was used for
gating. Because of the limited availability of samples for some
subjects at their first malaria episode, flow cytometry analyses
could not be performed on the entire study population.
In vitro functional profile of NK cells
Peripheral blood mononuclear cells isolated from malaria-
na€ıve buffy coats were stimulated with 20 ng mL!1 of PMA
and 1000 ng mL!1 of Ionomycin (Sigma-Aldrich) for 1 h at
37°C. Monensin A (GolgiStop; BD Biosciences) was added,
and cells were incubated for a further 5 h at 37°C.
Stimulated cells were then stained with anti-human CD3,
CD56, HLA-DR, CD45RO and CD38 mAbs (as described above)
for 20 mins; fixed and permeabilised using the Cytofix/
Cytoperm kit (BD Biosciences) following the manufacturer’s
instructions; and then stained with either anti-human IFN-c-
FITC (4S.B3; BD Biosciences) and TNF-a-BV785 (Mab11;
BioLegend), or perforin-FITC (B-D48) and Granzyme-B-AF647
(QA16A02) (both BioLegend) mAbs. Functional profile of NK
cells was analysed on a BD LSRFortessa X20 driven by
FACSDiva software (BD Biosciences). FlowJo software version
10.4 was used for gating.
NKG2C profile of NK cells
Peripheral blood mononuclear cells isolated from malaria-
na€ıve buffy coats were stimulated with 20 ng mL!1 of PMA
and 1000 ng mL!1 of Ionomycin (Sigma-Aldrich) for 6 h.
Stimulated PBMCs were stained with CD3, CD56, HLA-DR,
CD45RO, CD38 (as described above) and NKG2C-VioBright
FITC (REA205; Miltenyi Biotec, Bergisch Gladbach, Germany)
mAbs for 20 min. Cells were analysed as described above.
Statistical analysis
Statistical analyses were performed with Prism 7 (GraphPad
Software, Inc., San Diego, CA). Statistical tests used are
indicated for each Table and Figure. Normality was assessed
by either the d’Agostino–Pearson normality test or the
Shapiro–Wilk normality test, if ‘n’ is too small. P-values
< 0.05 were considered statistically significant.
Study approval
The Malian cohort study was conducted in compliance with
all applicable federal regulations governing protection of
human subjects and was approved by the Ethics Committee
of the Faculty of Medicine, Pharmacy and Dentistry at the
University of Sciences, Technique and Technology of
Bamako and the Institutional Review Board of the National
Institute of Allergy and Infectious Diseases, National
Institutes of Health. The study is registered on http://www.c
linicaltrials.gov (NCT01322581). Written informed consent
was obtained from the parents or guardians of participating
children. The laboratory study with samples collected during
that study was approved by the James Cook University
Human Research Ethics Committee (#H7735). Subjects with
no reported history of malaria or malaria exposure (malaria-
na€ıve, n = 6) were provided by the Australian Red Cross
under a protocol approved by the James Cook University
Human Research Ethics Committee (#H6702); written
informed consent was obtained from all subjects.
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